Therapeutic Potential of Axl Blockade in BCR-ABL Negative Myeloproliferative Neoplasms (MPN)

被引：0

作者：

Beitzen-Heineke, Antonia ^{[1
,2
,3
]}

Ben Batalla, Isabel ^{[1
,2
,3
]}

Berenbrok, Nikolaus ^{[1
,2
,3
]}

Paesler, Sarina ^{[1
,2
,3
]}

Gensch, Victoria ^{[1
,2
,3
]}

von Amsberg, Gunhild ^{[1
,2
]}

Schafhausen, Philippe ^{[1
,2
]}

Riecken, Kristoffer ^{[4
]}

Fischer, Thomas ^{[5
]}

Pantel, Klaus ^{[3
]}

Bokemeyer, Carsten ^{[1
,2
]}

Loges, Sonja ^{[1
,2
,3
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Univ Comprehens Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol,Sect BMT, Hamburg, Germany

[2] Univ Med Ctr Hamburg Eppendorf, Univ Comprehens Canc Ctr Hamburg, Hubertus Wald Tumorzentrum, Dept Hematol & Oncol,Sect Pneumol, Hamburg, Germany

[3] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Inst Tumor Biol, Hamburg, Germany

[4] Univ Med Ctr Hamburg Eppendorf, Res Dept Cell & Gene Therapy, Dept Stem Cell Transplantat, Hamburg, Germany

[5] Otto Von Guericke Univ, Dept Hematol & Oncol, Magdeburg, Germany

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-118175

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3063

引用

页数：3

共 50 条

[31] Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms
Kiladjian, J-J
Chomienne, C.
Fenaux, P.
LEUKEMIA, 2008, 22 (11) : 1990 - 1998
[32] The Role of β-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study
Geduk, Ayfer
Atesoglu, Elif B.
Tarkun, Pinar
Mehtap, Ozgur
Hacihanefioglu, Abdullah
Demirsoy, Esra T.
Baydemir, Canan
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 (12): : 785 - 789
[33] Association of mast cells and bone marrow reticulin fibrosis in patients with bcr-abl negative chronic myeloproliferative neoplasms
Keski, Hakan
BLOOD CELLS MOLECULES AND DISEASES, 2020, 82
[34] JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms
Giraldo-Rincon, Ana Isabel
Molina, Sara Naranjo
Gomez-Lopera, Natalia
Acevedo, Daniel Aguirre
Benavidez, Andrea Ucroz
Cardenas, Kenny Galvez
Ambrosi, Francisco Cuellar
Torres, Jose Domingo
Ospina, Sigifredo
Palacio, Katherine
Jaramillo, Lina Gaviria
Muneton, Carlos Mario
Palacio, Gonzalo Vasquez
COLOMBIA MEDICA, 2023, 54 (03):
[35] Diagnostic and therapeutic pitfalls of the BCR-ABL1 negative myeloproliferative neoplasms (MPNs) associated thromboembolism
Schilling, K.
ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 132 - 132
[36] Mutational analysis in BCR-ABL-negative classic myeloproliferative neoplasms: impact on prognosis and therapeutic choices
Tefferi, Ayalew
LEUKEMIA & LYMPHOMA, 2010, 51 (04) : 576 - 582
[37] Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnosticprinciples and upcoming updates
Geyer, J. T.
Orazi, A.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 12 - 19
[38] Potential Applications of Liquid Biopsy in BCR-ABL1-Negative Myeloproliferative Neoplasms: A Systematic Review
Gaman, Mihnea-Alexandru
Cozma, Matei-Alexandru
Dobrica, Elena-Codruta
Cretoiu, Sanda Maria
Gaman, Amelia Maria
Diaconu, Camelia Cristina
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S364 - S365
[39] Dissecting Genomic Aberrations In CML and Bcr-Abl Negative Myeloproliferative Neoplasms By The Use Of Multiplex-PCR and Parallel Resequencing
Kirschner, Martin M.
Schemionek, Mirle
Schubert, Claudia
Chatain, Nicolas
Sontag, Stephanie
Isfort, Susanne
Ortiz-Bruechle, Nadina
Bennemann, Karla
Zerres, Klaus
Zenke, Martin
Bruemmendorf, Tim H.
Koschmieder, Steffen
BLOOD, 2013, 122 (21)
[40] Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as novel prognostic biomarkers in BCR-ABL negative myeloproliferative neoplasms
Cvetkovic, Mirjana
Arsenovic, Isidora
Smiljanic, Mihailo
Sobas, Marta
Bogdanovic, Andrija
Lekovic, Danijela
ANNALS OF HEMATOLOGY, 2024, 103 (11) : 4545 - 4556

← 1 2 3 4 5 →